DK1526178T3 - MSP-3-lignende genfamilie - Google Patents

MSP-3-lignende genfamilie

Info

Publication number: DK1526178T3
Authority: DK; Denmark
Prior art keywords: family; msp; gene; gene family; genes
Prior art date: 2003-10-24

Application number

DK03292673.5T

Other languages

English (en)

Inventor

Pierre Druilhe

Original Assignee

Pasteur Institut

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-10-24

Filing date

2003-10-24

Publication date

2010-01-18

2003-10-24 Application filed by Pasteur Institut filed Critical Pasteur Institut

2010-01-18 Application granted granted Critical

2010-01-18 Publication of DK1526178T3 publication Critical patent/DK1526178T3/da

Links

108090000623 proteins and genes Proteins 0.000 title abstract 4
101150067969 MSP-3 gene Proteins 0.000 abstract 1
241000223960 Plasmodium falciparum Species 0.000 abstract 1
238000012512 characterization method Methods 0.000 abstract 1
230000002163 immunogen Effects 0.000 abstract 1
230000005847 immunogenicity Effects 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
244000045947 parasite Species 0.000 abstract 1
208000037369 susceptibility to malaria Diseases 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Biophysics (AREA)
Medicinal Chemistry (AREA)
Zoology (AREA)
Biochemistry (AREA)
Toxicology (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Tropical Medicine & Parasitology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Saccharide Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK03292673.5T 2003-10-24 2003-10-24 MSP-3-lignende genfamilie DK1526178T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP03292673A EP1526178B1 (en)	2003-10-24	2003-10-24	MSP-3-like family of genes

Publications (1)

Publication Number	Publication Date
DK1526178T3 true DK1526178T3 (da)	2010-01-18

Family

ID=34384722

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK03292673.5T DK1526178T3 (da)	2003-10-24	2003-10-24	MSP-3-lignende genfamilie

Country Status (15)

Country	Link
US (1)	US20070098738A1 (da)
EP (2)	EP1526178B1 (da)
CN (1)	CN1898384A (da)
AT (1)	ATE448307T1 (da)
AU (1)	AU2004283891B2 (da)
BR (1)	BRPI0415784A (da)
CA (1)	CA2542924A1 (da)
CY (1)	CY1110630T1 (da)
DE (1)	DE60330011D1 (da)
DK (1)	DK1526178T3 (da)
ES (1)	ES2335094T3 (da)
PT (1)	PT1526178E (da)
SI (1)	SI1526178T1 (da)
WO (1)	WO2005040203A2 (da)
ZA (1)	ZA200603296B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030161840A1 (en) *	1992-10-19	2003-08-28	Institut Pasteur	Plasmodium falciparum antigens inducing protective antibodies
FR2697022B1 (fr) *	1992-10-19	1994-12-16	Pasteur Institut	Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination.
EP2223937A1 (en) *	2009-02-27	2010-09-01	Institut Pasteur	Polypeptides for the prevention or treatment of malaria
FR2968560A1 (fr) *	2010-12-13	2012-06-15	Oreal	Utilisation de l'ide comme biomarqueur d'un etat du cuir chevelu
CN109295243A (zh) *	2018-12-14	2019-02-01	中国疾病预防控制中心寄生虫病预防控制所	鉴定间日疟原虫PvMSP-3α基因多态性的引物、方法及应用
CN113150101A (zh) *	2021-04-23	2021-07-23	中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心)	一种恶性疟原虫RIFIN重组蛋白PfRIFIN-55的构建、制备及用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2744724B1 (fr) *	1996-02-14	2002-08-02	Pasteur Institut	Proteine recombinante contenant un fragment c-terminal de la proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques

2003
- 2003-10-24 ES ES03292673T patent/ES2335094T3/es not_active Expired - Lifetime
- 2003-10-24 DK DK03292673.5T patent/DK1526178T3/da active
- 2003-10-24 AT AT03292673T patent/ATE448307T1/de active
- 2003-10-24 DE DE60330011T patent/DE60330011D1/de not_active Expired - Lifetime
- 2003-10-24 SI SI200331739T patent/SI1526178T1/sl unknown
- 2003-10-24 EP EP03292673A patent/EP1526178B1/en not_active Expired - Lifetime
- 2003-10-24 PT PT03292673T patent/PT1526178E/pt unknown
2004
- 2004-10-22 BR BRPI0415784-2A patent/BRPI0415784A/pt not_active IP Right Cessation
- 2004-10-22 EP EP04791104A patent/EP1689866A2/en not_active Withdrawn
- 2004-10-22 AU AU2004283891A patent/AU2004283891B2/en not_active Ceased
- 2004-10-22 CN CNA2004800386552A patent/CN1898384A/zh active Pending
- 2004-10-22 CA CA002542924A patent/CA2542924A1/en not_active Abandoned
- 2004-10-22 WO PCT/EP2004/012909 patent/WO2005040203A2/en not_active Ceased
2006
- 2006-04-24 US US11/409,174 patent/US20070098738A1/en not_active Abandoned
- 2006-04-25 ZA ZA2006/03296A patent/ZA200603296B/en unknown
2010
- 2010-01-05 CY CY20101100018T patent/CY1110630T1/el unknown

Also Published As

Publication number	Publication date
WO2005040203A2 (en)	2005-05-06
US20070098738A1 (en)	2007-05-03
PT1526178E (pt)	2010-02-03
HK1075066A1 (en)	2005-12-02
AU2004283891B2 (en)	2010-10-07
AU2004283891A1 (en)	2005-05-06
CY1110630T1 (el)	2015-04-29
EP1526178A1 (en)	2005-04-27
EP1689866A2 (en)	2006-08-16
CA2542924A1 (en)	2005-05-06
BRPI0415784A (pt)	2006-12-26
DE60330011D1 (de)	2009-12-24
WO2005040203A3 (en)	2005-06-23
CN1898384A (zh)	2007-01-17
ZA200603296B (en)	2007-10-31
ATE448307T1 (de)	2009-11-15
ES2335094T3 (es)	2010-03-22
SI1526178T1 (sl)	2010-03-31
EP1526178B1 (en)	2009-11-11

Similar Documents

Publication	Publication Date	Title
IL214460A0 (en)	2011-09-27	Malaria prime/boost vaccines
IN2014DN08830A (da)	2015-07-10
CY2013036I2 (el)	2015-12-09	Συνθεσεις εμβολιου κατα της ναϊσσερια, που περιεχουν εναν συνδυασμο αντιγονων
WO2006068663A3 (en)	2006-11-16	Vaccine compositions for treating coronavirus infection
CY1113078T1 (el)	2016-04-13	Συνθεση πολυσθενους εμβολιου
SG156535A1 (en)	2009-11-26	Recombinant viral-based malaria vaccines
MA30581B1 (fr)	2009-07-01	Vaccin viral recombinant
UY31285A1 (es)	2009-03-31	Vacunas
IL199126A (en)	2010-12-30	Promoters for expression in modified vaccinia virus ankara (mva) and vectors comprising said promoters.
EA200600403A1 (ru)	2006-08-25	Препараты кладрибина для улучшенной пероральной доставки и доставки через слизистые оболочки
DK1356822T3 (da)	2011-02-07	Farmaceutiske sammensætninger, der forøger immunogeniteten af svagt immunogene antigener
CY1110630T1 (el)	2015-04-29	Οικογενεια γονιδιων παρομοιων με τα msp-3
BRPI0515334A (pt)	2008-07-22	uso de um antìgeno de plasmodium
WO2008086386A3 (en)	2008-10-23	Adenoviral vector-based malaria vaccines
DK1599225T3 (da)	2007-09-24	Sammensætninger og fremgangsmåder til frembringelsen af beskyttende immunrespons mod malaria
DK1697405T3 (da)	2013-01-02	LSA-5 leverstadium- og blodstadium-antigen fra Plasmodium falciparum, immunogent præparat omfattende dette antigen samt vacciner mod malaria
DE50312368D1 (de)	2010-03-11	Rekombinante mva-stamme als potentielle impfstoffe gegen p. falciparum -malaria
WO2002092628A3 (fr)	2003-09-25	Antigenes de plasmodium falciparum et leurs applications vaccinales et diagnostiques
WO2007006052A3 (en)	2007-11-15	Malaria msp-1 c-terminal enhanced subunit vaccine
HK1097277A (en)	2007-06-22	Lsa-5 liver stage and blood stage antigen of plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria
ITMI20020433A0 (it)	2002-03-01	Epitopi antigenici di gp100/pme117